The Boeing Company and Subsidiaries

Consolidated Statements of Cash Flows

(Dollars in millions)
Years ended December 31, 2022 2021 2020
Cash flows – operating activities:
Net loss ($5,053) ($4,290) ($11,941)
Adjustments to reconcile net loss to net cash used by operating activities:
Non-cash items –
Share-based plans expense 725 833 250
Treasury shares issued for 401(k) contribution 1,215 1,233 195
Depreciation and amortization 1,979 2,144 2,246
Investment/asset impairment charges, net 112 98 410
Customer financing valuation adjustments 37 12
Gain on dispositions, net (6) (277) (202)
787 and 777X reach-forward losses 3,460 6,493
Other charges and credits, net 364 360 1,462
Changes in assets and liabilities –
Accounts receivable 142 (713) 909
Unbilled receivables 6 (586) 919
Advances and progress billings 108 2,505 (1,060)
Inventories 420 (1,127) (11,002)
Other current assets (591) 345 372
Accounts payable 838 (3,783) (5,363)
Accrued liabilities 2,956 (3,687) 1,074
Income taxes receivable, payable and deferred 1,347 733 (2,576)
Other long-term liabilities (158) (206) (222)
Pension and other postretirement plans (1,378) (972) (794)
Customer financing, net 142 210 173
Other 307 304 235
Net cash provided/(used) by operating activities 3,512 (3,416) (18,410)
Cash flows – investing activities:
Payments to acquire property, plant and equipment (1,222) (980) (1,303)
Proceeds from disposals of property, plant and equipment 35 529 296
Acquisitions, net of cash acquired (6)
Contributions to investments (5,051) (35,713) (37,616)
Proceeds from investments 10,619 45,489 20,275
Other (11) 5 (18)
Net cash provided/(used) by investing activities 4,370 9,324 (18,366)
Cash flows – financing activities:
New borrowings 34 9,795 47,248
Debt repayments (1,310) (15,371) (10,998)
Stock options exercised 50 42 36
Employee taxes on certain share-based payment arrangements (40) (66) (173)
Dividends paid (1,158)
Net cash (used)/provided by financing activities (1,266) (5,600) 34,955
Effect of exchange rate changes on cash and cash equivalents (73) (39) 85
Net increase/(decrease) in cash & cash equivalents, including restricted 6,543 269 (1,736)
Cash & cash equivalents, including restricted, at beginning of year 8,104 7,835 9,571
Cash & cash equivalents, including restricted, at end of year 14,647 8,104 7,835
Less restricted cash & cash equivalents, included in Investments 33 52 83
Cash and cash equivalents at end of year $14,614 $8,052 $7,752

See Notes to the Consolidated Financial Statements on pages 59 - 114.

56